Considering the available evidence which suggests that BPA can variably impact on the expression of TMPRSS2, further research is needed in order to explore whether any such BPA-induced effects on this key SARS-CoV-2 infection mediator may have a clinically relevant impact on the risk of developing COVID-19 and its subsequent severity. The gene discussed is TMPRSS2; the disease is COVID-19.